Community-based access to oral antiviral treatments for COVID-19 in Australia.
Aust J Gen Pract
; 52(6): 409-412, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: covidwho-20243349
ABSTRACT
BACKGROUND:
The availability of oral antivirals for SARS-CoV-2 infection reduces the risk of severe, acute illness in people at higher risk for death and hospitalisation.OBJECTIVE:
The process for antiviral prescription and dispensing in Australia is outlined using nationwide data.DISCUSSION:
Australia has focused on providing rapid access to antivirals to high-risk people in the community via general practices and community pharmacies. Although the introduction of oral antiviral treatments is an important part of the response to the COVID-19 pandemic, vaccination remains the most effective way of mitigating the risk of developing severe complications of COVID-19, including hospitalisation and death.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
COVID-19
Tipo de estudio:
Estudio pronóstico
Tópicos:
Vacunas
Límite:
Humanos
País/Región como asunto:
Oceanía
Idioma:
Inglés
Revista:
Aust J Gen Pract
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS